ChenGuang Biotech Group Co., Ltd. (300138.SZ)
CNY 10.57
(-3.21%)
CNY 10.57
(-3.21%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 548.32 Million CNY | -1.37% |
| 2022 | 487.01 Million CNY | 26.54% |
| 2021 | 384.86 Million CNY | 23.73% |
| 2020 | 311.05 Million CNY | 53.15% |
| 2019 | 203.1 Million CNY | 43.84% |
| 2018 | 141.19 Million CNY | 7.62% |
| 2017 | 131.2 Million CNY | 35.41% |
| 2016 | 96.89 Million CNY | 68.56% |
| 2015 | 57.48 Million CNY | 390.65% |
| 2014 | 11.71 Million CNY | 1.71% |
| 2013 | 11.51 Million CNY | -71.87% |
| 2012 | 40.95 Million CNY | -47.99% |
| 2011 | 78.73 Million CNY | 20.22% |
| 2010 | 65.49 Million CNY | 19.4% |
| 2009 | 54.85 Million CNY | 27.1% |
| 2008 | 43.15 Million CNY | 161.96% |
| 2007 | 16.47 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 59.4 Million CNY | -7.54% |
| 2024 Q1 | 64.25 Million CNY | 4.17% |
| 2024 Q3 | -47.55 Million CNY | -180.04% |
| 2023 Q4 | 61.68 Million CNY | -44.35% |
| 2023 FY | 480.35 Million CNY | -1.37% |
| 2023 Q1 | 154.39 Million CNY | 40.05% |
| 2023 Q2 | 199.58 Million CNY | 29.27% |
| 2023 Q3 | 110.84 Million CNY | -44.46% |
| 2022 Q2 | 143.98 Million CNY | 23.08% |
| 2022 Q3 | 115.79 Million CNY | -19.57% |
| 2022 Q4 | 110.24 Million CNY | -4.8% |
| 2022 FY | 487.01 Million CNY | 26.54% |
| 2022 Q1 | 116.98 Million CNY | 15.42% |
| 2021 Q4 | 101.35 Million CNY | 29.76% |
| 2021 FY | 384.86 Million CNY | 23.73% |
| 2021 Q1 | 90.91 Million CNY | 26.95% |
| 2021 Q2 | 114.5 Million CNY | 25.95% |
| 2021 Q3 | 78.1 Million CNY | -31.79% |
| 2020 Q2 | 113.91 Million CNY | 68.19% |
| 2020 Q1 | 67.72 Million CNY | 59.51% |
| 2020 Q3 | 57.8 Million CNY | -49.26% |
| 2020 FY | 311.05 Million CNY | 53.15% |
| 2020 Q4 | 71.61 Million CNY | 23.9% |
| 2019 Q3 | 39.11 Million CNY | -40.66% |
| 2019 FY | 203.1 Million CNY | 43.84% |
| 2019 Q1 | 55.62 Million CNY | 905.81% |
| 2019 Q2 | 65.9 Million CNY | 18.48% |
| 2019 Q4 | 42.45 Million CNY | 8.56% |
| 2018 FY | 141.19 Million CNY | 7.62% |
| 2018 Q4 | 5.53 Million CNY | -82.55% |
| 2018 Q3 | 31.69 Million CNY | -44.41% |
| 2018 Q2 | 57.01 Million CNY | 21.44% |
| 2018 Q1 | 46.95 Million CNY | 137.53% |
| 2017 Q4 | 19.76 Million CNY | -42.65% |
| 2017 Q2 | 45.21 Million CNY | 42.39% |
| 2017 Q1 | 31.75 Million CNY | 434.38% |
| 2017 FY | 131.2 Million CNY | 35.41% |
| 2017 Q3 | 34.46 Million CNY | -23.77% |
| 2016 Q3 | 29.08 Million CNY | -21.66% |
| 2016 FY | 96.89 Million CNY | 68.56% |
| 2016 Q1 | 24.73 Million CNY | 44.5% |
| 2016 Q2 | 37.12 Million CNY | 50.1% |
| 2016 Q4 | 5.94 Million CNY | -79.57% |
| 2015 Q1 | 2.46 Million CNY | -70.87% |
| 2015 FY | 57.48 Million CNY | 390.65% |
| 2015 Q2 | 31.39 Million CNY | 1172.48% |
| 2015 Q3 | 6.5 Million CNY | -79.28% |
| 2015 Q4 | 17.11 Million CNY | 163.15% |
| 2014 Q3 | 3.19 Million CNY | 248.12% |
| 2014 Q4 | 8.46 Million CNY | 164.82% |
| 2014 FY | 11.71 Million CNY | 1.71% |
| 2014 Q1 | 2.2 Million CNY | -70.31% |
| 2014 Q2 | -2.15 Million CNY | -197.76% |
| 2013 Q4 | 7.43 Million CNY | 168.82% |
| 2013 Q2 | 2.61 Million CNY | -78.72% |
| 2013 Q1 | 12.27 Million CNY | 97.24% |
| 2013 FY | 11.51 Million CNY | -71.87% |
| 2013 Q3 | -10.8 Million CNY | -513.75% |
| 2012 Q3 | -979.94 Thousand CNY | -105.1% |
| 2012 Q1 | 16.48 Million CNY | -8.09% |
| 2012 Q4 | 6.22 Million CNY | 735.17% |
| 2012 FY | 40.95 Million CNY | -47.99% |
| 2012 Q2 | 19.22 Million CNY | 16.6% |
| 2011 Q1 | 34.33 Million CNY | 122.61% |
| 2011 FY | 78.73 Million CNY | 20.22% |
| 2011 Q4 | 17.93 Million CNY | -1.64% |
| 2011 Q3 | 18.23 Million CNY | 121.56% |
| 2011 Q2 | 8.23 Million CNY | -76.03% |
| 2010 FY | 65.49 Million CNY | 19.4% |
| 2010 Q2 | 11.07 Million CNY | -59.78% |
| 2010 Q3 | 11.44 Million CNY | 3.34% |
| 2010 Q4 | 15.42 Million CNY | 34.7% |
| 2010 Q1 | 27.54 Million CNY | 119.19% |
| 2009 FY | 54.85 Million CNY | 27.1% |
| 2009 Q3 | 6.46 Million CNY | 0.0% |
| 2009 Q4 | 12.56 Million CNY | 94.48% |
| 2008 FY | 43.15 Million CNY | 161.96% |
| 2007 FY | 16.47 Million CNY | 0.0% |